The Diary Of A CEO
The Diary Of A CEO publishes in-depth interview and podcast-style episodes that explore leadership, technology, economics and culture. Content often surfaces thematic market implications—especially around AI, labor, and large-cap tech—but is primarily interview-driven rather than market-focused analysis.
Past bets that played out
Recurring thematic calls: AI and AGI disruption (material implications for labor and tech capex); platform and large-cap tech narratives (OPENAI, NVDA, MSFT, AMZN); geopolitical and institutional themes (SPACEX, ANTHROPIC). Standout episodes flagged for market relevance include exclusive political interviews and AI-focused conversations that highlight long-term structural risks and investment opportunities.
Podcast-style narrative featuring Mo Gawdat warning AGI has effectively arrived, rapid AI-driven productivity gains, and major labor displacement (claim: ~30% jobs gone by 2027). The content is thematic and speculative; no concrete company-specific catalysts, but it supports medium-term AI capex/software beneficiaries and raises regulatory/anti-tech sentiment risk.
Podcast-style narrative featuring Mo Gawdat warning AGI has effectively arrived, rapid AI-driven productivity gains, and major labor displacement (claim: ~30% jobs gone by 2027). The content is thematic and speculative; no concrete company-specific catalysts, but it supports medium-term AI capex/software beneficiaries and raises regulatory/anti-tech sentiment risk.
Podcast-style narrative featuring Mo Gawdat warning AGI has effectively arrived, rapid AI-driven productivity gains, and major labor displacement (claim: ~30% jobs gone by 2027). The content is thematic and speculative; no concrete company-specific catalysts, but it supports medium-term AI capex/software beneficiaries and raises regulatory/anti-tech sentiment risk.
What this channel is watching now
Top tickers and themes currently discussed: OPENAI (high conviction), ANTHROPIC (very high conviction), LMT, AMZN, SPACEX, WMT, NVDA, MSFT. Episodes frequently address AI’s productivity and labor impacts, with recurring conversations on macro/consumer pressure in the UK and thematic health/wellness topics that carry low direct market actionability.
Latest videos and market context
Recent notable episodes include an exclusive interview with Vice President JD Vance, an expert discussion on creatine and aging with Dr. Darren Candow, a long-form conversation with Graham Hancock on ancient history, and a debate on UK middle-class economic pressures. Content ranges from political exclusives to health and thematic cultural conversations.
EXCLUSIVE - Vice President JD Vance: They Tricked Me About Donald Trump, But Everything Changed!
Exclusive political interview with Vice President JD Vance. Primarily a political narrative; potential market implications are general (policy, sentiment) rather than company-specific or time-sensitive.
Anti-Aging Expert: Creatine Is The Fat Loss Secret Doctors Don’t Tell You - Dr. Darren Candow
Loosely transcribed health/podcast-style discussion claiming creatine supports fat loss/body composition, performance (ATP, training volume), and possibly brain/mitochondrial markers (BDNF). Brief mentions of side effects (GI irritation, water retention) and quality certification (NSF/Creapure). Contains no company-specific news, financial data, or catalyst timing—market actionability is low.
Graham Hancock: We've Forgotten the Warnings!
Fragmented transcript touching on ancient-impact/Younger Dryas hypotheses, Antarctic maps/longitude, rainforest/LiDAR, and psychedelics (DMT/ayahuasca). No concrete economic, corporate, policy, or financial-market information suitable for tradable catalysts.
Death of the Middle Class: Billionaire vs Entrepreneur DEBATE - Daniel Priestley v Nick Hanauer
Low-signal debate focused on UK middle-class squeeze (tax/VAT, thin margins, Brexit drag) and wealth concentration. Mentions of BlackRock, Jeff Bezos/Amazon, and JP Morgan are passing. Actionable angle: macro/consumer thesis—UK consumer discretionary and pubs may be under pressure; defensives and discount retailers could hold up; large asset managers may benefit from institutional housing/financialization trends.
Proof-backed call history
The Diary Of A CEO has built an audience through long-form interviews and narrative podcasts that attract business leaders, entrepreneurs, scientists and public figures. The channel’s output is interview-first; market implications are often thematic rather than tied to immediate, tradable catalysts.
EXCLUSIVE - Vice President JD Vance: They Tricked Me About Donald Trump, But Everything Changed!
The source is a loosely transcribed health/podcast-style discussion claiming creatine supports fat loss/body composition, performance (ATP, training volume), and possibly brain/mitochondrial markers (BDNF), with brief mentions of side effects (GI irritation, water retention) and quality certification (NSF/Creapure). It contains no company-specific news, financial data, or catalyst timing—so market actionability is low.
The source is a loosely transcribed health/podcast-style discussion claiming creatine supports fat loss/body composition, performance (ATP, training volume), and possibly brain/mitochondrial markers (BDNF), with brief mentions of side effects (GI irritation, water retention) and quality certification (NSF/Creapure). It contains no company-specific news, financial data, or catalyst timing—so market actionability is low.
The source is a loosely transcribed health/podcast-style discussion claiming creatine supports fat loss/body composition, performance (ATP, training volume), and possibly brain/mitochondrial markers (BDNF), with brief mentions of side effects (GI irritation, water retention) and quality certification (NSF/Creapure). It contains no company-specific news, financial data, or catalyst timing—so market actionability is low.
The source is a loosely transcribed health/podcast-style discussion claiming creatine supports fat loss/body composition, performance (ATP, training volume), and possibly brain/mitochondrial markers (BDNF), with brief mentions of side effects (GI irritation, water retention) and quality certification (NSF/Creapure). It contains no company-specific news, financial data, or catalyst timing—so market actionability is low.
The source is a loosely transcribed health/podcast-style discussion claiming creatine supports fat loss/body composition, performance (ATP, training volume), and possibly brain/mitochondrial markers (BDNF), with brief mentions of side effects (GI irritation, water retention) and quality certification (NSF/Creapure). It contains no company-specific news, financial data, or catalyst timing—so market actionability is low.
The source is a loosely transcribed health/podcast-style discussion claiming creatine supports fat loss/body composition, performance (ATP, training volume), and possibly brain/mitochondrial markers (BDNF), with brief mentions of side effects (GI irritation, water retention) and quality certification (NSF/Creapure). It contains no company-specific news, financial data, or catalyst timing—so market actionability is low.
The source is a fragmented transcript about Graham Hancock, ancient impact/Younger Dryas hypotheses, Antarctica maps/longitude, rainforest/LiDAR, and discussion of DMT/ayahuasca. It contains no concrete economic, corporate, policy, or financial-market information that can be mapped to tradable catalysts.
The source is a fragmented transcript about Graham Hancock, ancient impact/Younger Dryas hypotheses, Antarctica maps/longitude, rainforest/LiDAR, and discussion of DMT/ayahuasca. It contains no concrete economic, corporate, policy, or financial-market information that can be mapped to tradable catalysts.
...hropic guys say, "Oh, actually we're just going to restructure to Vanuatu now. Leave you guys holding all of that toxic debt and we're going to go run this from somewhere else." That could happen. The other thing that could happen is if let's say OpenAI as one example are making $100 profit at the moment $100 profit at the moment and Bernie Sanders says we want $50 of that profit. China are going to have an additional theoretically an additional $50 to invest in their frontier models in getti
...t in society is artificial intelligence. And we you probably saw recently Eric Schmidt did a commencement speech in front of thousands of students and every time he said the word stage >> every time he said the word AI um one of the things that Anthropic or one of the leading AI companies said recently is that entry- level jobs are at risk and I've got this graph here showing the decline of entrylevel job postings. I believe it was on LinkedIn um pull from somewhere and it shows that they're
Low-signal debate transcript focused on UK middle-class squeeze (tax/VAT, thin margins, Brexit drag) and wealth concentration. Mentions BlackRock buying housing, Jeff Bezos/Amazon, and JP Morgan only in passing. Actionable angle is mainly a macro/consumer thesis: UK consumer discretionary and pubs under pressure; defensives/discount may hold up; large asset managers potentially benefit from institutional housing/financialization themes.
About this channel
The Diary Of A CEO (handle: thediaryofaceo on YouTube) produces interview-led episodes and conversations exploring leadership, entrepreneurship, technology and society. Viewers should expect high-quality narrative interviews that occasionally highlight macro and thematic investment implications—especially around AI and labor displacement—but not routine company-level or financial-report analysis.
64% of our viewers don't realise they don't subscribe, please double check, thank you!!
Most recognized assets
Unlock the full track record
Subscribe on YouTube and follow the channel handle @thediaryofaceo for new episodes and exclusive interviews. Note: 64% of viewers reportedly don't realize they aren’t subscribed—please double-check your subscription settings to receive updates.
54 more thesis calls are available after sign-up.